Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 0.39.

  • Gossamer Bio's Equity Ratio fell 35554.83% to 0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39, marking a year-over-year decrease of 35554.83%. This contributed to the annual value of 0.09 for FY2024, which is 5351.81% down from last year.
  • Per Gossamer Bio's latest filing, its Equity Ratio stood at 0.39 for Q3 2025, which was down 35554.83% from 0.19 recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Equity Ratio ranged from a high of 0.3 in Q3 2023 and a low of 0.39 during Q3 2025
  • For the 4-year period, Gossamer Bio's Equity Ratio averaged around 0.02, with its median value being 0.09 (2024).
  • Within the past 5 years, the most significant YoY rise in Gossamer Bio's Equity Ratio was 35397.85% (2023), while the steepest drop was 41605.76% (2023).
  • Over the past 4 years, Gossamer Bio's Equity Ratio (Quarter) stood at 0.04 in 2022, then soared by 353.98% to 0.2 in 2023, then tumbled by 53.52% to 0.09 in 2024, then tumbled by 521.51% to 0.39 in 2025.
  • Its last three reported values are 0.39 in Q3 2025, 0.19 for Q2 2025, and 0.02 during Q1 2025.